Sangamo Therapeutics, Inc. (SGMOQ)
Develops gene therapies to treat rare genetic diseases like hemophilia and Fabry disease.
$0.07+0.03%
StockGlow Score
Bearish
BearishBullish
1 year ago-88.0%
The outlook
Sangamo is trading near its 52-week low at $0.067, well below both its 50- and 200-day moving averages. Analyst coverage appears thin on this stock. The current price sits just 5% of the way from its yearly low to high, reflecting sustained weakness in the biotech name.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range5% of the way from its 52-week low to high
Market cap
—
52-wk high
$0.77
52-wk low
$0.03
50-day avg
$0.12
200-day avg
$0.34
Trailing P/E
—